Guidance for industry : nucleic acid testing (NAT) to reduce the possible risk of parvovirus B19 transmission by plasma-derived products.
| Corporate Author: | |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
Rockville, MD :
U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,
[2008]
|
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/LPS111638 |
| Item Description: | Title from PDF title page (viewed on Apr. 21, 2009). "Draft guidance." "July 2008." Electronic resource. |
|---|---|
| Physical Description: | i, 5 pages : digital, PDF file. |
| Format: | Mode of access: Internet at the FDA CBER Web site. Address as of 4/21/09: http://www.fda.gov/cber/gdlns/natparo.pdf ; current access is available via PURL. |
| Bibliography: | Includes bibliographical references (pages 4-5). |